Site updated at Wednesday, 22 June 2016

Living with Dementia

Statins May Cut Parkinson’s Risk

  • - Dementia News
  • Mar 13, 2012
  • Comments
  • Viewed: 1362
Tags: | cholesterol-lowering drugs | lipid-lowering drugs | parkinson's disease | parkinson's disease risk |

Statin users may get an added benefit from the cardioprotective lipid-lowering - a modestly reduced risk of developing Parkinson’s disease, researchers found.

Men and women in two large prospective cohorts were 26% less likely to develop Parkinson’s disease if they were taking a statin than if they weren’t currently on one (adjusted pooled P=0.049), Xiang Gao, MD, PhD, of Harvard and Brigham and Women’s Hospital in Boston, and colleagues reported in the March issue of the Archives of Neurology.

The benefit appeared limited to statin users under age 60 at baseline, who saw a bigger impact of the drug with an adjusted pooled relative risk of 0.31 (P=0.02 for effect, P=0.03 for interaction with age).

Preclinical studies have pointed to several mechanisms of statins, such as a reducing oxidative stress, that would be expected to alleviate neuroinflammation and thus Parkinson’s disease risk, Gao’s group explained.

However, “the overall epidemiological evidence relating statin use to Parkinson’s disease risk remains unconvincing,” the group cautioned, so the marginally significant overall result in their analysis might have been due to chance.

But at least there didn’t appear to be a negative impact, a possibility, they noted, because statins lower plasma coenzyme Q10 levels, which may be neuroprotective in Parkinson’s disease.

- Note that in this prospective study, the risk of Parkinson’s disease was marginally significantly lower among current statin users compared with nonusers.
- Point out that the association was observed principally in participants younger than 60 years of age.

Statins aren’t entirely benign, as the FDA has repeatedly highlighted in recent months through warnings added to the label regarding the risk of diabetes and transient memory problems with drugs across the class and a caution about drug-drug interactions with HIV/AIDS and hepatitis C medications.

“Given the potential adverse effects of statins, further prospective observational studies are needed to explore the potential effects of different subtypes of statins on risk of Parkinson’s disease and other neurodegenerative diseases,” Gao and colleagues concluded.

For their study, the researchers pooled the data on 38,192 men participating in the Health Professionals Follow-up Study and 90,874 women in the Nurses’ Health Study.

So what are those risk factors?

If you are 60 or over you are more likely to get PD. Seventy-five percent of all cases of PD begin after age 60 and incidence increases every decade after that up to about 80 years of age. If you do not have PD by age 80 your chances of getting it are small and are substantially lower than when they were when you were 70 or 60. Most people develop initial symptoms of PD in middle age. The idea is that dopamine production declines with age and you start to feel that decline in middle age. When the decline is steep and profound you get PD.

Men are slightly more at risk than women to get PD. Nobody knows why men are more vulnerable to PD than women. It may be that the female hormone estrogen protects dopamine neurons to some extent.

If someone in your family - a close blood relative for example - has or had PD, then your chances of getting PD are slightly increased. Familial forms of PD suggest that certain genetic problems may contribute to the causes of PD. An abnormality in one such gene, Parkin, may be a predictor of the onset of Parkinson’s at a young age (before age 50). Alpha Synuclein is another gene implicated in PD. When damaged it contributes to abnormal clumping of dopamine cells (called Lewy bodies).

Excessive exposure to industrial toxic chemicals such as pesticides and herbicides can increase the risk of developing PD. People who live in a rural agricultural area and used well water for drinking and cooking were found to have higher rates of PD, possibly because they were exposed to toxic chemicals in the form of pesticides.

Among them, 3,306 of the men and 7,729 of the women reported taking a cholesterol-lowering drug at least twice a week on questionnaires at the analysis baseline in 1994.

The lower incidence of Parkinson’s disease among them during 12 years of follow-up was evident despite adjustment for age, smoking, caffeine and lactose consumption, ibuprofen use, history of major chronic disease, and other factors.

Page 1

1 2 Next »

Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]

Your details

* Required field

Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

What is dementia?

learning1 - α-synuclein protein2 - amyloid-beta protein1 - blast-induced traumatic brain injury1 - medium spiny neurons1 - national alzheimer's project act1 - tavi2 - sundowning2 - niaiserie1 - physical exercise1 - depression14 - causes of the dementia1 - cardiac surgery2 - mild tbi1 - paraphrenia1 - dementia friends1 - omega-3s1 - artery-clogging process1 - microrna1 - senile atrophy and aphasia1 - alzheimer's research5 - type of dementia4 - beta amyloid3 - pre-dementia stage1 - aids related dementia1 - exercise games1 - vci1 - neurobiology1 - common form of dementia1 - social withdrawal1 -